China Universal Asset Management Co., Ltd. Harrow Health, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,825 shares of HROW stock, worth $233,415. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,825
Previous 4,157
64.18%
Holding current value
$233,415
Previous $86,000
255.81%
% of portfolio
0.03%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding HROW
# of Institutions
178Shares Held
21.3MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$136 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$74 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$73.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$63.8 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$25 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $926M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...